Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth

Biochem Biophys Res Commun. 1998 Nov 18;252(2):513-6. doi: 10.1006/bbrc.1998.9682.

Abstract

Previously, we reported that the rabbit prothrombin fragment 2 (kringle 2 domain) has an anti-endothelial cell proliferative effect (Lee et al., J. Biol. Chem., in press). In this report, we show that not only rabbit prothrombin fragment 2 but also human prothrombin fragment 1 and 2 have an inhibitory effect on bFGF-stimulated BCE cell growth. Human prothrombin fragment 1 and 2 obtained as proteolytic fragments of human prothrombin display potent inhibitory effects on bovine capillary endothelial cells with a half-maximal concentration (ED50) of approximately 100 nM and 120 nM, respectively. As rabbit prothrombin fragment 2, the human prothrombin fragment 1 and 2 also inhibit angiogenesis in the chorioallantoic membrane (CAM) of chick embryos.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allantois / blood supply
  • Allantois / drug effects
  • Animals
  • Cattle
  • Cell Division / drug effects*
  • Cells, Cultured
  • Chick Embryo
  • Chorion / blood supply
  • Chorion / drug effects
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / drug effects*
  • Fibroblast Growth Factor 2 / pharmacology*
  • Humans
  • Neovascularization, Physiologic / drug effects
  • Peptide Fragments / pharmacology*
  • Protein Precursors / pharmacology*
  • Prothrombin / pharmacology*
  • Rabbits

Substances

  • Peptide Fragments
  • Protein Precursors
  • Fibroblast Growth Factor 2
  • prothrombin fragment 1
  • prothrombin fragment 2
  • Prothrombin